Retraction notice to “Berberine ameliorates renal injury in diabetic C57BL/6 mice: Involvement of suppression of SphK–S1P signaling pathway” [Arch. Biochem. Biophys. 502(2010) 112–120, (S0003986110002912), (10.1016/j.abb.2010.07.012)];Berberine ameliorates renal injury in diabetic C57BL/6 mice: Involvement of suppression of SphK-S1P signaling pathway

Archives of Biochemistry and Biophysics

Volumn 502, Issue 2, 2010, Pages 112-120

  Lan, Tian ^a   Shen, Xiaoyan ^a   Liu, Peiqing ^a   Liu, Weihua ^a   Xu, Suowen ^a   Xie, Xi ^a   Jiang, Qin ^a   Li, Wenyuan ^a   Huang, Heqing ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

Berberine; Diabetic nephropathy; Extracellular matrix; Renoprotection; SphK S1P signaling pathway; TGF 1

Indexed keywords

BERBERINE; COLLAGEN TYPE 4; FIBRONECTIN; SPHINGOSINE 1 PHOSPHATE; SPHINGOSINE KINASE; TRANSFORMING GROWTH FACTOR BETA1; GLUCOSE; LYSOPHOSPHOLIPID; PHOSPHOTRANSFERASE; SPHINGOSINE; SPHINGOSINE 1-PHOSPHATE;

ALBUMINURIA; ALLOXAN DIABETES MELLITUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETIC NEPHROPATHY; DOWN REGULATION; ENZYME ACTIVITY; GLUCOSE BLOOD LEVEL; IMMUNOHISTOCHEMISTRY; KIDNEY HYPERTROPHY; KIDNEY INJURY; KIDNEY MASS; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; RENAL PROTECTION; SIGNAL TRANSDUCTION; UREA NITROGEN BLOOD LEVEL; ANALOGS AND DERIVATIVES; ANIMAL; C57BL MOUSE; DIABETES MELLITUS; DRUG EFFECTS; EXPERIMENTAL DIABETES MELLITUS; KIDNEY; METABOLISM; PATHOLOGY; RANDOMIZATION;

MUS; RATTUS;

ALBUMINURIA; ANIMALS; BERBERINE; DIABETES MELLITUS; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEPHROPATHIES; GLUCOSE; KIDNEY; LYSOPHOSPHOLIPIDS; MALE; MICE; MICE, INBRED C57BL; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR); RANDOM ALLOCATION; SIGNAL TRANSDUCTION; SPHINGOSINE; TRANSFORMING GROWTH FACTOR BETA1;

EID: 77956339397     PISSN: 00039861     EISSN: 10960384     Source Type: Journal    
DOI: 10.1016/j.abb.2023.109636     Document Type: Erratum

References (36)

1. Raptis A.E., Viberti G. Exp. Clin. Endocrinol. Diabetes 2001, 109(Suppl. 2):S424-S437.
2. Schena F.P., Gesualdo L. J. Am. Soc. Nephrol. 2005, 16(Suppl. 1):S30-S33.
3. Kanwar Y.S., Akagi S., Sun L., Nayak B., Xie P., Wada J., Chugh S.S., Danesh F.R. Nephron 2005, 101:e100-e110.
4. Keane W.F., Lyle P.A. Am. J. Kidney Dis. 2003, 41:S22-S25.
5. Pyne S., Pyne N.J. Biochem. J. 2000, 349:385-402.
6. Spiegel S., Milstien S. Nat. Rev. 2003, 4:397-407.
7. Wang L., Xing X.P., Holmes A., Wadham C., Gamble J.R., Vadas M.A., Xia P. Circ. Res. 2005, 97:891-899.
8. You B., Ren A., Yan G., Sun J. Diabetes 2007, 56:1445-1453.
9. Geoffroy K., Wiernsperger N., Lagarde M., El Bawab S. J. Biol. Chem. 2004, 279:34343-34352.
10. Geoffroy K., Troncy L., Wiernsperger N., Lagarde M., El Bawab S. FEBS Lett. 2005, 579:1249-1254.
11. Klawitter S., Hofmann L.P., Pfeilschifter J., Huwiler A. Br. J. Pharmacol. 2007, 150:271-280.
12. Yin J., Xing H., Ye J. Metab. Clin. Exp. 2008, 57:712-717.
13. Katsuma S., Hada Y., Ueda T., Shiojima S., Hirasawa A., Tanoue A., Takagaki K., Ohgi T., Yano J., Tsujimoto G. Genes Cells 2002, 7:1217-1230.
14. Hanafusa N., Yatomi Y., Yamada K., Hori Y., Nangaku M., Okuda T., Fujita T., Kurokawa K., Fukagawa M. Nephrol. Dial. Transplant. 2002, 17:580-586.
15. Yin J., Gao Z., Liu D., Liu Z., Ye J. Am. J. Physiol. 2008, 294:E148-E156.
16. Lee Y.S., Kim W.S., Kim K.H., Yoon M.J., Cho H.J., Shen Y., Ye J.M., Lee C.H., Oh W.K., Kim C.T., Hohnen-Behrens C., Gosby A., Kraegen E.W., James D.E., Kim J.B. Diabetes 2006, 55:2256-2264.
17. Kong W., Wei J., Abidi P., Lin M., Inaba S., Li C., Wang Y., Wang Z., Si S., Pan H., Wang S., Wu J., Wang Y., Li Z., Liu J., Jiang J.D. Nat. Med. 2004, 10:1344-1351.
18. Hattori T., Furuta K., Nagao T., Nagamatsu T., Ito M., Suzuki Y. Jpn. J. Pharmacol. 1992, 59:159-169.
19. Marinova E.K., Nikolova D.B., Popova D.N., Gallacher G.B., Ivanovska N.D. Immunopharmacology 2000, 48:9-16.
20. Liu W.H., Hei Z.Q., Nie H., Tang F.T., Huang H.Q., Li X.J., Deng Y.H., Chen S.R., Guo F.F., Huang W.G., Chen F.Y., Liu P.Q. Chin. Med. J. 2008, 121:706-712.
21. Liu W., Liu P., Tao S., Deng Y., Li X., Lan T., Zhang X., Guo F., Huang W., Chen F., Huang H., Zhou S.F. Arch. Biochem. Biophys. 2008, 475:128-134.
22. Liu W., Tang F., Deng Y., Li X., Lan T., Zhang X., Huang H., Liu P. Mol. Cell. Biochem. 2009, 325:99-105.
23. Pfaffl M.W. Nucleic Acids Res. 2001, 29:e45.
24. Olivera A., Rosenthal J., Spiegel S. J. Cell. Biochem. 1996, 60:529-537.
25. Lan T., Bi H.C., Xu S.W., Le K., Xie Z.Y., Liu Y.W., Huang H.Q. Biomed. Chromatogr. 2010, 10.1002/bmc.1407.
26. Weston B.S., Wahab N.A., Mason R.M. J. Am. Soc. Nephrol. 2003, 14:601-610.
27. Ziyadeh F.N. Am. J. Kidney Dis. 1993, 22:736-744.
28. Nicholas S.B. Cell. Mol. Biol. (Noisy-le-Grand, France) 2003, 49:1319-1325.
29. Sharma K., Jin Y., Guo J., Ziyadeh F.N. Diabetes 1996, 45:522-530.
30. Pugliese G., Pricci F., Romeo G., Pugliese F., Mene P., Giannini S., Cresci B., Galli G., Rotella C.M., Vlassara H., Di Mario U. Diabetes 1997, 46:1881-1887.
31. Murphy M., Docherty N.G., Griffin B., Howlin J., McArdle E., McMahon R., Schmid H., Kretzler M., Droguett A., Mezzano S., Brady H.R., Furlong F., Godson C., Martin F. J. Am. Soc. Nephrol. 2008, 19:1672-1680.
32. Zuo F., Nakamura N., Akao T., Hattori M. Drug Metab. Dispos. 2006, 34:2064-2072.
33. Chai Q., Krag S., Chai S., Ledet T., Wogensen L. Histochem. Cell Biol. 2003, 119:267-280.
34. Wang A., Ziyadeh F.N., Lee E.Y., Pyagay P.E., Sung S.H., Sheardown S.A., Laping N.J., Chen S. Am. J. Physiol. 2007, 293:F1657-F1665.
35. Russo L.M., Comper W.D. Kidney Int. Suppl. 2004, S67-S68.
36. Katsuma S., Ruike Y., Yano T., Kimura M., Hirasawa A., Tsujimoto G. FEBS Lett. 2005, 579:2576-2582.